HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingchang Mi Selected Research

Imatinib Mesylate (Gleevec)

9/2014EUTOS score predicts survival and cytogenetic response in patients with chronic phase chronic myeloid leukemia treated with first-line imatinib.
7/2014[Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review].
11/2009Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingchang Mi Research Topics

Disease

21Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 03/2008
19Leukemia
04/2024 - 03/2003
16Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 11/2009
8Philadelphia Chromosome
08/2023 - 11/2014
6Sepsis (Septicemia)
01/2024 - 12/2020
5Infections
11/2023 - 01/2017
5Acute Promyelocytic Leukemia
12/2022 - 08/2014
4Chromosome Aberrations (Chromosome Abnormalities)
06/2015 - 07/2009
2Neutropenia
11/2023 - 01/2017
2Neoplasms (Cancer)
11/2023 - 09/2011
2Bacteremia
01/2023 - 03/2022
2Hematologic Diseases (Blood Diseases)
01/2023 - 03/2022
2Genomic Instability
12/2021 - 09/2011
2Cytokine Release Syndrome
10/2020 - 05/2020
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2014 - 07/2014
1Inflammation (Inflammations)
03/2024
1Aplastic Anemia (Anemia, Hypoplastic)
11/2023
1Hematologic Neoplasms (Hematological Malignancy)
11/2023
1Febrile Neutropenia
10/2023
1Invasive Fungal Infections
01/2022
1Skin Neoplasms (Skin Cancer)
05/2020
1Brain Diseases (Brain Disorder)
05/2020
1Lymphoma (Lymphomas)
05/2020
1Candidemia
01/2020
1Genetic Translocation (Chromosomal Translocation)
12/2017
1Wilms Tumor (Wilm's Tumor)
09/2017
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
04/2016
1Mycoses (Diseases, Fungus)
01/2015
1Pulmonary Arterial Hypertension
07/2014
1Dyspnea (Shortness of Breath)
07/2014
1Autoimmune Diseases (Autoimmune Disease)
03/2003

Drug/Important Bio-Agent (IBA)

9Cytarabine (Cytosar-U)FDA LinkGeneric
05/2023 - 03/2008
6Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 12/2020
6venetoclaxIBA
05/2023 - 09/2021
4Proteins (Proteins, Gene)FDA Link
11/2023 - 03/2003
3HomoharringtonineIBA
04/2022 - 03/2008
3Dasatinib (BMS 354825)FDA Link
01/2021 - 07/2014
3Chimeric Antigen ReceptorsIBA
10/2020 - 01/2020
3Peroxidase (Myeloperoxidase)IBA
04/2016 - 12/2011
3Imatinib Mesylate (Gleevec)FDA Link
09/2014 - 11/2009
2Carbapenems (Carbapenem Antibiotics)IBA
01/2024 - 01/2023
2Daunorubicin (Cerubidine)FDA LinkGeneric
05/2023 - 03/2008
2Methotrexate (Mexate)FDA LinkGeneric
01/2023 - 01/2023
2Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2022 - 03/2015
2Cytokine Receptors (Cytokine Receptor)IBA
04/2018 - 01/2018
2Mitoxantrone (Novantrone)FDA LinkGeneric
02/2016 - 03/2008
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
08/2012 - 10/2011
1Serum AlbuminIBA
04/2024
1fms-Like Tyrosine Kinase 3IBA
01/2024
1Tetracycline (Achromycin)FDA LinkGeneric
11/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2023
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2023
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2023
1Phosphotransferases (Kinase)IBA
08/2023
1Arsenic Trioxide (Trisenox)FDA Link
12/2022
1posaconazoleFDA Link
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1alanyl-leucyl-alanyl-leucine (ALAL)IBA
09/2021
1Azacitidine (5 Azacytidine)FDA Link
09/2021
1QuinolonesIBA
12/2020
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
12/2020
1ruxolitinibIBA
10/2020
1SteroidsIBA
10/2020
1CytokinesIBA
10/2020
1Janus KinasesIBA
10/2020
1Antifungal AgentsIBA
01/2020
1nilotinibFDA Link
03/2019
1CBFbeta-MYH11 fusion proteinIBA
10/2018
1Core Binding Factors (Core-Binding Factor)IBA
10/2018
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2018
1Co-Repressor ProteinsIBA
04/2018
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1Pyridinolcarbamate (P23)IBA
12/2017
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
12/2017
1Serine Proteases (Serine Protease)IBA
09/2017
1HLA-DR Antigens (HLA-DR)IBA
01/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2016
1AntigensIBA
06/2015
1Caspofungin (Cancidas)FDA Link
01/2015
1CateninsIBA
12/2014
1RetinoidsIBA
08/2014
1AcidsIBA
08/2014
1Cadherins (E-Cadherin)IBA
05/2014
1HeterochromatinIBA
02/2014
1Arginine (L-Arginine)FDA Link
08/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
09/2011
1DNA (Deoxyribonucleic Acid)IBA
08/2011
1OligonucleotidesIBA
02/2011
1Poly (ADP-Ribose) Polymerase-1IBA
03/2003
1AutoantibodiesIBA
03/2003

Therapy/Procedure

15Therapeutics
03/2024 - 03/2008
8Drug Therapy (Chemotherapy)
05/2023 - 11/2009
3Hematopoietic Stem Cell Transplantation
01/2023 - 12/2014
2Induction Chemotherapy
01/2017 - 07/2009
2Consolidation Chemotherapy
01/2017 - 03/2015
2Transplantation
06/2015 - 05/2014
1Immunotherapy
12/2022
1Aftercare (After-Treatment)
12/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
05/2020
1Ligation
04/2018